Daniel Gesua Sive Salvadori — Senior Vice President of Established Pharmaceuticals - Latin America at Abbott

Mr. Daniel Gesua Sive Salvadori has been Senior Vice President of Established Pharmaceuticals - Latin America at Abbott Laboratories since September 2014. Mr. Salvadori served as President of CFR Pharmaceuticals S.A. Mr. Salvadori served as Chief Executive Officer of Latam at CFR Pharmaceuticals S.A. Mr. Salvadori served as the Director of Corporate Development of Oriel Therapeutics, Inc. He served as Executive President of Complex Therapeutics at CFR Pharmaceuticals S.A. Mr. Salvadori worked in the business development and corporate strategy as a Executive at Medtronic, Inc. Mr. Salvadori has a strong background in the investment community. Mr. Salvadori served as Vice President with New Leaf Venture Partners and in the investment banking group of Lehman Brothers, in Tel Aviv and in New York, where he worked on several financings and M&A assignments for a number of medical devices and pharmaceutical clients. He serves as Chairman of CFR Pharmaceuticals S.A. Prior to New Leaf, Mr. Salvadori worked in business development and corporate strategy at Medtronic (MDT). Prior to joining Lehman Brothers, Mr. Salvadori worked as a Teaching Assistant in Finance for the Hebrew University of Jerusalem. He holds a B.A. in Economics from the Hebrew University of Jerusalem, where he graduated magna cum laude and holds am M.B.A. with distinction from the Harvard Business School.